-0.14 | -0.26%
| Price and Volume | |
|---|---|
| Recent Price | 53.32 |
| 52 Week High | 56.20 |
| 52 Week Low | 41.35 |
| Avg. Daily Vol. (Mil) | 2.73 |
| Beta (3 year) | 0.93 |
| Share Related Items | |
| Mkt Cap (Mil) | 25,715.07 |
| Shares Out (Mil) | 482.28 |
| Float (Mil) | 481.96 |
| Dividend Information | |
| Yield % | 1.70 |
| Annual Dividend | 0.90 |
| Payout Ratio | 21.00 |
| Financial Strength | |
| Quick Ratio | 1.30 |
| Current Ratio | 2.30 |
| LT Debt/ Equity | 0.36 |
| Total Debt / Equity | 0.41 |
| Valuation Ratios | |
| Price Earnings | 13.20 |
| Price/Sales | 2.17 |
| Price/Book | 2.44 |
| Price/Cash Flow | 9.90 |
| Per Share Data | |
| Earnings | 4.03 |
| Sales | 24.57 |
| Book Value | 21.84 |
| Cash Flow | 5.38 |
| Business Summary | |
|---|---|
| Covidien PLC is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, Pharmaceuticals and Medical Supplies. | |
| General Information | |
| 20 on Hatch
Lower Hatch Street Dublin 2, |
|
| www.covidien.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 41300 | |
| CEO: Jose E. Almeida | |
| Short Interest | |
| Current Month (Mil) | 6.13 |
| Previous Month (Mil) | 5.88 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | 18.80 |
| Return on Assets | 9.30 |
| Return on Investments | 13.80 |
| Profitability | |
| Gross Margin | 62.80 |
| EBIT Margin | 21.10 |
| Profit Margin | 16.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet